Literature DB >> 1519976

Prediction of impaired metabolic adaptation by antenatal Doppler studies in small for gestational age fetuses.

J M Hawdon1, M P Ward Platt, S McPhail, H Cameron, S A Walkinshaw.   

Abstract

The increased risk of hypoglycaemia for infants who are small for gestational age (SGA) is well known, and further information regarding metabolic adaptation can be gained by examining the profiles of glucose and other metabolic fuels in such infants. Not all SGA infants experience hypoglycaemia, however, and the ability to identify, antenatally, those at most risk would be helpful for obstetric and neonatal management. This study investigated metabolic differences between two groups of SGA infants who had antenatal umbilical artery Doppler studies. Fourteen had end diastolic velocities (EDV) present and 11 had absent EDV. The absent EDV group had significantly lower non-esterified fatty acid (NEFA) concentrations at birth, and lower blood glucose and NEFA concentrations in the first six hours after birth. After the first day, few metabolic differences were found between the two groups. Antenatal Doppler studies may identify those SGA infants who fail to achieve neonatal metabolic adaptation and are most at risk of early neonatal hypoglycaemia.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1519976      PMCID: PMC1590432          DOI: 10.1136/adc.67.7_spec_no.789

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  15 in total

1.  Hypoglycaemia in the newborn. A sequel of intrauterine malnutrition.

Authors:  G A NELIGAN; E ROBSON; J WATSON
Journal:  Lancet       Date:  1963-06-15       Impact factor: 79.321

2.  Symptomatic neonatal hypoglycemia associated with toxemia of pregnancy.

Authors:  M CORNBLATH; G B ODELL; E Y LEVIN
Journal:  J Pediatr       Date:  1959-11       Impact factor: 4.406

3.  Umbilical amino acid concentrations in normal and growth-retarded fetuses sampled in utero by cordocentesis.

Authors:  I Cetin; C Corbetta; L P Sereni; A M Marconi; P Bozzetti; G Pardi; F C Battaglia
Journal:  Am J Obstet Gynecol       Date:  1990-01       Impact factor: 8.661

4.  Adverse neurodevelopmental outcome of moderate neonatal hypoglycaemia.

Authors:  A Lucas; R Morley; T J Cole
Journal:  BMJ       Date:  1988-11-19

5.  Relation of blood-glucose to haematocrit, birthweight, and other body measurements in normal and growth-retarded newborn infants.

Authors:  J C Haworth; L Dilling; M K Younoszai
Journal:  Lancet       Date:  1967-10-28       Impact factor: 79.321

6.  Is intrauterine growth retardation with normal umbilical artery blood flow a benign condition?

Authors:  G Burke; B Stuart; P Crowley; S N Scanaill; J Drumm
Journal:  BMJ       Date:  1990-04-21

7.  Prenatal asphyxia, hyperlacticaemia, hypoglycaemia, and erythroblastosis in growth retarded fetuses.

Authors:  P W Soothill; K H Nicolaides; S Campbell
Journal:  Br Med J (Clin Res Ed)       Date:  1987-04-25

8.  Body size and neonatal hypoglycemia in intrauterine growth retardation.

Authors:  I Járai; J Mestyán; K Schultz; A Lázár; M Halász; I Krassy
Journal:  Early Hum Dev       Date:  1977-10       Impact factor: 2.079

9.  Hypertriglyceridemia and hypoxemia in small-for-gestational-age fetuses.

Authors:  D L Economides; D Crook; K H Nicolaides
Journal:  Am J Obstet Gynecol       Date:  1990-02       Impact factor: 8.661

10.  Limited role of fetal blood sampling in prediction of outcome in intrauterine growth retardation.

Authors:  U Nicolini; P Nicolaidis; N M Fisk; J I Vaughan; L Fusi; R Gleeson; C H Rodeck
Journal:  Lancet       Date:  1990-09-29       Impact factor: 79.321

View more
  2 in total

Review 1.  Hypoglycaemia of the newborn: a review.

Authors:  A F Williams
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

Review 2.  Prevention and management of neonatal hypoglycaemia.

Authors:  J M Hawdon; M P Ward Platt; A Aynsley-Green
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-01       Impact factor: 5.747

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.